SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-020116
Filing Date
2021-04-22
Accepted
2021-04-22 16:19:47
Documents
6
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A avro-def14a_20210610.htm DEF 14A 829495
2 GRAPHIC gtnfftrjw0rr000003.jpg GRAPHIC 22640
3 GRAPHIC gtnfftrjw0rr000005.jpg GRAPHIC 88814
4 GRAPHIC gtnfftrjw0rr000001.jpg GRAPHIC 22640
5 GRAPHIC gtnfftrjw0rr000004.jpg GRAPHIC 580374
6 GRAPHIC gtnfftrjw0rr000002.jpg GRAPHIC 6591
  Complete submission text file 0001564590-21-020116.txt   1823755
Mailing Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 7819626030
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38537 | Film No.: 21845041
SIC: 2836 Biological Products, (No Diagnostic Substances)